How Marques was paid
$640,059 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Total |
|---|---|---|---|---|
| Tiago Reis MarquesChief Executive Officer | $450,000 | $22,241 | $167,818 | $640,059 |
| Daniel SchneidermanChief Financial Officer | $330,000 | — | $100,223 | $430,223 |
| Graeme CurrieChief Development Officer | $386,535 | — | $48,276 | $434,811 |
What changed and why
- $640KChief Executive Officer Tiago Reis Marques received total compensation of $640,059 in 2024, representing an increase from $537,347 in 2023.
- $450KChief Executive Officer base salary remained unchanged at $450,000 for fiscal year 2024.
- $168KStock and option awards contributed significantly to executive compensation, with option awards valued at $167,818 for the CEO.
- $430KChief Financial Officer Daniel Schneiderman earned total compensation of $430,223 in 2024 compared to $345,939 in 2023.
Other Pasithea Therapeutics proxy statements
- 2026 proxy statement
Tiago Reis Marques paid $1.3M (+107% on the year).
Filed Aug 07, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.